BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32599298)

  • 21. Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.
    Wang B; Tisch R
    Immunol Res; 2008; 42(1-3):246-58. PubMed ID: 19052699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to post-translationally modified insulin in type 1 diabetes.
    Strollo R; Vinci C; Arshad MH; Perrett D; Tiberti C; Chiarelli F; Napoli N; Pozzilli P; Nissim A
    Diabetologia; 2015 Dec; 58(12):2851-60. PubMed ID: 26350612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
    van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
    Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beta cell immunopeptidome.
    Dudek NL; Purcell AW
    Vitam Horm; 2014; 95():115-44. PubMed ID: 24559916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97.
    Hoelen H; Zaldumbide A; van Leeuwen WF; Torfs EC; Engelse MA; Hassan C; Lebbink RJ; de Koning EJ; Resssing ME; de Ru AH; van Veelen PA; Hoeben RC; Roep BO; Wiertz EJ
    PLoS One; 2015; 10(6):e0128206. PubMed ID: 26107514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
    Crèvecoeur I; Rondas D; Mathieu C; Overbergh L
    Proteomics Clin Appl; 2015 Aug; 9(7-8):755-66. PubMed ID: 25641783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
    Strollo R; Vinci C; Napoli N; Pozzilli P; Ludvigsson J; Nissim A
    Diabetologia; 2017 Aug; 60(8):1467-1474. PubMed ID: 28526919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes.
    Piganelli JD; Mamula MJ; James EA
    Front Endocrinol (Lausanne); 2020; 11():624590. PubMed ID: 33679609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the T Cell Receptor as a Biomarker in Type 1 Diabetes.
    Nakayama M; Michels AW
    Front Immunol; 2021; 12():777788. PubMed ID: 34868047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.
    Delong T; Wiles TA; Baker RL; Bradley B; Barbour G; Reisdorph R; Armstrong M; Powell RL; Reisdorph N; Kumar N; Elso CM; DeNicola M; Bottino R; Powers AC; Harlan DM; Kent SC; Mannering SI; Haskins K
    Science; 2016 Feb; 351(6274):711-4. PubMed ID: 26912858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding type 1 diabetes through proteomics.
    Crèvecoeur I; Vig S; Mathieu C; Overbergh L
    Expert Rev Proteomics; 2017 Jul; 14(7):571-580. PubMed ID: 28649880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.
    Strollo R; Vinci C; Man YKS; Bruzzaniti S; Piemonte E; Alhamar G; Briganti SI; Malandrucco I; Tramontana F; Fanali C; Garnett J; Buccafusca R; Guyer P; Mamula M; James EA; Pozzilli P; Ludvigsson J; Winyard PG; Galgani M; Nissim A
    Diabetologia; 2023 Jan; 66(1):132-146. PubMed ID: 36207582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioengineering strategies for inducing tolerance in autoimmune diabetes.
    Baekkeskov S; Hubbell JA; Phelps EA
    Adv Drug Deliv Rev; 2017 May; 114():256-265. PubMed ID: 28625830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
    J Immunol Res; ; . PubMed ID: 29651443
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.